How has been the historical performance of Brooks Lab.?

Answer:The historical performance of Brooks Lab shows a fluctuating trend in key financial metrics over the past five years.

Breakdown:
Brooks Lab's net sales have seen a gradual increase from 63.20 Cr in Mar'23 to 82.56 Cr in Mar'25, with a peak of 91.08 Cr in Mar'22. However, total operating income followed a similar pattern, reaching 82.56 Cr in Mar'25 after a low of 63.20 Cr in Mar'23. The total expenditure, excluding depreciation, decreased from 105.44 Cr in Mar'22 to 77.62 Cr in Mar'25, contributing to an operating profit (PBDIT) of 5.82 Cr in Mar'25, a significant recovery from a loss of -26.22 Cr in Mar'23. Profit before tax also improved to 3.19 Cr in Mar'25 from a loss of -35.07 Cr in Mar'23, leading to a profit after tax of 3.01 Cr in Mar'25, compared to a loss of -27.74 Cr in Mar'23. Despite these improvements, the consolidated net profit remained negative at -9.97 Cr in Mar'25, although it was an improvement from -19.59 Cr in Mar'24. The company's total assets decreased from 194.56 Cr in Mar'22 to 90.45 Cr in Mar'24, while total liabilities also fell from 162.08 Cr in Mar'21 to 90.45 Cr in Mar'24. Cash flow from operating activities remained negative at -9.00 Cr in Mar'24, indicating ongoing challenges in cash generation despite some operational improvements.